In head and neck cancer, several retrospective studies have reported the presence of mutations of genes in cohorts of largely HPV-negative HNSCC, most notably TP53, PIK3CA, CDKN2A, the TERT promoter, and NOTCH pathway gene alterations (136–139). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.